Active-ingredient Dossier
Hydrochlorothiazide
Active-ingredient Dossier for Hydrochlorothiazide (thiazide diuretic). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: ATACAND
- Brand: AVAPRO
- Brand: DILART
- Brand: DITHIAZIDE
- Brand: SEVIKAR
- Brand: TEVETEN
- Therapeutic area: Cardiology
What is
Hydrochlorothiazide Hydrochlorothiazide is a thiazide diuretic.
Australian brands containing
Hydrochlorothiazide — AVAPRO — DITHIAZIDE — SEVIKAR — OLMETEC — CO-DIOVAN — ABISART — ADESAN — AKM-OLMESARTAN HCTZ — APO- — APO-CANDESARTAN — APX-OLMESARTAN/HCTZ — CANDESARTAN HCTZ-WGR
Therapeutic areas
Hydrochlorothiazide is registered in cardiology (51 brands) and women's health (1 brand).
Sponsor landscape
Hydrochlorothiazide is marketed by 17 sponsors, including Arrotex Pharmaceuticals, Pharmacor, GM Pharma, Sandoz, Sun Pharma and Alphapharm.
PBS and regulatory activity
Two brands containing hydrochlorothiazide have PBS-listed items, with the latest PBS schedule date being 1 May 2026. In 2014–15, government spending on hydrochlorothiazide-containing brands was $34.1 million across 2.08 million prescriptions. The latest PBAC outcome was recorded on 1 July 2013, and the latest AusPAR on 11 September 2013.